Winifred Ekezie

Dr. Winifred Ekezie

University of Leicester, Leicester, UK
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 October 2021 in Journal of Migration and Health
Verified
Journal Article
Open access
DCDavid Cantor
David Cantor
JSJina Swartz
Jina Swartz
BRBayard Roberts
Bayard Roberts
AAAula Abbara
Aula Abbara
AAAlastair Ager
Alastair Ager
JSJames Smith
James Smith
• Internal displacement due to conflict or violence can have profound health impacts. • IDPs tend to experience worse health outcomes than other conflict-affected populations. • That reflects the particular vulnerabilities of IDPs relative to these other populations. • Health interventions need to take account of the specific vulnerabilities of IDPs.

28 June 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
WEWinifred Ekezie
Winifred Ekezie
SASamy Awwad
Samy Awwad
AKArja Krauchenberg
Arja Krauchenberg
NKNora Karara
Nora Karara
ŁDŁukasz Dembiński
Łukasz Dembiński
UPUte Panzenboeck
Ute Panzenboeck
Vaccination has a significant impact on morbidity and mortality. High vaccination coverage rates are required to achieve herd protection against vaccine-preventable diseases. However, limited vaccine access and hesitancy among specific communities represent significant obstacles to this goal. This review provides an overview of critical factors associated with vaccination among disadvantaged groups in World Health Organisation European countries. Initial searches yielded 18,109 publications from four databases, and 104 studies from 19 out of 53 countries reporting 22 vaccine-preventable diseases were included. Nine groups representing the populations of interest were identified, and most of the studies focused on asylum seekers, refugees, migrants and deprived communities. Recall of previous vaccinations received was poor, and serology was conducted in some cases to confirm protection for those who received prior vaccinations. Vaccination coverage was lower among study populations compared to the general population or national average. Factors that influenced uptake, which presented differently at different population levels, included health service accessibility, language and vaccine literacy, including risk perception, disease severity and vaccination benefits. Strategies that could be implemented in vaccination policy and programs were also identified. Overall, interventions specific to target communities are vital to improving uptake. More innovative strategies need to be deployed to improve vaccination coverage among disadvantaged groups.

7 May 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
LOLauren L. O’mAhoney
Lauren L. O’mAhoney
Ash RoutenAsh Routen
Ash Routen
CGClare Gillies
Clare Gillies
SJSian A. Jenkins
Sian A. Jenkins
Abdullah AlmaqhawiAbdullah Almaqhawi
Abdullah Almaqhawi
KKKamlesh Khunti
Kamlesh Khunti
The global evidence on the risk of symptoms of Long Covid in general populations infected with SARS-CoV-2 compared to uninfected comparator/control populations remains unknown. We conducted a systematic literature search using multiple electronic databases from January 1, 2022, to August 1, 2024. Included studies had ≥100 people with confirmed or self-reported COVID-19 at ≥28 days following infection onset, and an uninfected comparator/control group. Results were summarised descriptively and meta-analyses were conducted to derive pooled risk ratio estimates. 50 studies totaling 14,661,595 people were included. In all populations combined, there was an increased risk of a wide range of 39 out of 40 symptoms in those infected with SARS‑CoV‑2 compared to uninfected controls. The symptoms with the highest pooled relative risks were loss of smell (RR 4.31; 95% CI 2.66, 6.99), loss of taste (RR 3.71; 95% CI 2.22, 7.26), poor concentration (RR 2.68; 95% CI 1.66, 4.33), impaired memory (RR 2.53; 95% CI 1.82, 3.52), and hair loss/alopecia (RR 2.38; 95% CI 1.69, 3.33). This evidence synthesis, of 50 controlled studies with a cumulative participant count exceeding 14 million people, highlights a significant risk of diverse long-term symptoms in individuals infected with SARS-CoV-2, especially among those who were hospitalised.

19 December 2018 in Environmental Science and Pollution Research
Verified
Journal Article
Open access
PDF file
EAEnemona Emmanuel Adaji
Enemona Emmanuel Adaji
WEWinifred Ekezie
Winifred Ekezie
Mike CliffordMike Clifford
Mike Clifford
RPRevati Phalkey
Revati Phalkey
Exposure to indoor air pollution increases the risk of pneumonia in children, accounting for about a million deaths globally. This study investigates the individual effect of solid fuel, carbon monoxide (CO), black carbon (BC) and particulate matter (PM)2.5 on pneumonia in children under 5 in low- and middle-income countries. A systematic review was conducted to identify peer-reviewed and grey full-text documents without restrictions to study design, language or year of publication using nine databases (Embase, PubMed, EBSCO/CINAHL, Scopus, Web of Knowledge, WHO Library Database (WHOLIS), Integrated Regional Information Networks (IRIN), the World Meteorological Organization (WMO)-WHO and Intergovernmental Panel on Climate Change (IPCC). Exposure to solid fuel use showed a significant association to childhood pneumonia. Exposure to CO showed no association to childhood pneumonia. PM2.5 did not show any association when physically measured, whilst eight studies that used solid fuel as a proxy for PM2.5 all reported significant associations. This review highlights the need to standardise measurement of exposure and outcome variables when investigating the effect of air pollution on pneumonia in children under 5. Future studies should account for BC, PM1 and the interaction between indoor and outdoor pollution and its cumulative impact on childhood pneumonia.

30 October 2020 in Journal of Public Health
Verified
Journal Article
Closed access
WEWinifred Ekezie
Winifred Ekezie
BCBarbara M Czyznikowska
Barbara M Czyznikowska
SRSundeep Rohit
Sundeep Rohit
JHJulian Harrison
Julian Harrison
NMNasima Miah
Nasima Miah
KKKamlesh Khunti
Kamlesh Khunti

27 November 2024 in Vaccines
Verified
Journal Article
Open access
PDF file
WEWinifred Ekezie
Winifred Ekezie
BIBeauty Igein
Beauty Igein
Jomon Philip VarugheseJomon Philip Varughese
Jomon Philip Varughese
ABAyesha Butt
Ayesha Butt
BUBlessing Onyinye Ukoha-kalu
Blessing Onyinye Ukoha-kalu
GBGenevieve Bosah
Genevieve Bosah
Background: African countries experience high rates of infectious diseases that are mostly preventable by vaccination. Despite the risks of infections and other adverse outcomes, vaccination coverage in the African region remains significantly low. Poor vaccination knowledge is a contributory factor, and effective communication is crucial to bridging the vaccination uptake gap. This review summarises vaccination communication strategies adopted across African countries and associated changes in vaccine uptake. Methods: A systematic search was conducted in five bibliographic databases between 2000 and 2023 and supplemented with an additional Google Scholar search. Studies with data on vaccination communication and uptake in the English language were considered. A narrative synthesis was performed, and findings were presented in text and tables. Findings: Forty-one studies from fourteen African countries met the inclusion criteria. Several communication strategies were implemented for 13 different vaccines, mainly childhood vaccines. Mass campaigns and capacity building were the most common strategies for the public and health workers, respectively. Community-based strategies using social mobilisation effectively complemented other communication strategies.Overall, vaccination uptake increased in all countries following vaccination communication interventions. Barriers and facilitators to optimising vaccination communication at systemic and individual levels were also identified. Key barriers included lack of vaccine information, access issues, and high cost, while facilitators included improved vaccine education, reminders, trust-building initiatives, and community involvement. Conclusions: This review highlights effective vaccination communication strategies implemented across Africa as well as systemic and individual barriers and facilitators influencing vaccination uptake. The findings can inform strategies for vaccination communication and campaign planning to improve vaccination coverage in Africa.